Indo US Bio-Tech standalone net profit rises 607.69% in the March 2025 quarter
27 - May - 2025 12:00 | 19 days ago
Net profit of Indo US Bio-Tech rose 607.69% to Rs 3.68 crore in the quarter ended March 2025 as against Rs 0.52 crore during the previous quarter ended March 2024. Sales rose 111.67% to Rs 33.38 crore in the quarter ended March 2025 as against Rs 15.77 crore during the previous quarter ended March 2024.
For the full year,net profit rose 97.45% to Rs 16.27 crore in the year ended March 2025 as against Rs 8.24 crore during the previous year ended March 2024. Sales rose 42.56% to Rs 103.84 crore in the year ended March 2025 as against Rs 72.84 crore during the previous year ended March 2024.
Indo US Bio-Tech standalone net profit rises 37.23% in the December 2024 quarter
11 - Feb - 2025 12:00 | 124 days ago
Net profit of Indo US Bio-Tech rose 37.23% to Rs 5.05 crore in the quarter ended December 2024 as against Rs 3.68 crore during the previous quarter ended December 2023. Sales rose 6.56% to Rs 23.56 crore in the quarter ended December 2024 as against Rs 22.11 crore during the previous quarter ended December 2023.
Indo US Bio-Tech standalone net profit rises 37.23% in the December 2024 quarter
11 - Feb - 2025 12:00 | 124 days ago
Net profit of Indo US Bio-Tech rose 37.23% to Rs 5.05 crore in the quarter ended December 2024 as against Rs 3.68 crore during the previous quarter ended December 2023. Sales rose 6.56% to Rs 23.56 crore in the quarter ended December 2024 as against Rs 22.11 crore during the previous quarter ended December 2023.
Indo US Bio-Tech standalone net profit rises 607.69% in the March 2025 quarter
27 - May - 2025 12:00 | 19 days ago
Net profit of Indo US Bio-Tech rose 607.69% to Rs 3.68 crore in the quarter ended March 2025 as against Rs 0.52 crore during the previous quarter ended March 2024. Sales rose 111.67% to Rs 33.38 crore in the quarter ended March 2025 as against Rs 15.77 crore during the previous quarter ended March 2024.
For the full year,net profit rose 97.45% to Rs 16.27 crore in the year ended March 2025 as against Rs 8.24 crore during the previous year ended March 2024. Sales rose 42.56% to Rs 103.84 crore in the year ended March 2025 as against Rs 72.84 crore during the previous year ended March 2024.
Indo US Bio-Tech standalone net profit rises 37.23% in the December 2024 quarter
11 - Feb - 2025 12:00 | 124 days ago
Net profit of Indo US Bio-Tech rose 37.23% to Rs 5.05 crore in the quarter ended December 2024 as against Rs 3.68 crore during the previous quarter ended December 2023. Sales rose 6.56% to Rs 23.56 crore in the quarter ended December 2024 as against Rs 22.11 crore during the previous quarter ended December 2023.
Indo US Bio-Tech standalone net profit rises 607.69% in the March 2025 quarter
27 - May - 2025 12:00 | 19 days ago
Net profit of Indo US Bio-Tech rose 607.69% to Rs 3.68 crore in the quarter ended March 2025 as against Rs 0.52 crore during the previous quarter ended March 2024. Sales rose 111.67% to Rs 33.38 crore in the quarter ended March 2025 as against Rs 15.77 crore during the previous quarter ended March 2024.
For the full year,net profit rose 97.45% to Rs 16.27 crore in the year ended March 2025 as against Rs 8.24 crore during the previous year ended March 2024. Sales rose 42.56% to Rs 103.84 crore in the year ended March 2025 as against Rs 72.84 crore during the previous year ended March 2024.
Indo US Bio-Tech standalone net profit rises 37.23% in the December 2024 quarter
11 - Feb - 2025 12:00 | 124 days ago
Net profit of Indo US Bio-Tech rose 37.23% to Rs 5.05 crore in the quarter ended December 2024 as against Rs 3.68 crore during the previous quarter ended December 2023. Sales rose 6.56% to Rs 23.56 crore in the quarter ended December 2024 as against Rs 22.11 crore during the previous quarter ended December 2023.
Indo US Bio-Tech standalone net profit rises 37.23% in the December 2024 quarter
11 - Feb - 2025 12:00 | 124 days ago
Net profit of Indo US Bio-Tech rose 37.23% to Rs 5.05 crore in the quarter ended December 2024 as against Rs 3.68 crore during the previous quarter ended December 2023. Sales rose 6.56% to Rs 23.56 crore in the quarter ended December 2024 as against Rs 22.11 crore during the previous quarter ended December 2023.